Intestinal permeability and vitamin A absorption in patients with chemotherapy-induced diarrhea

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 31, Issue 6, 2008, Pages 580-584

  Melichar, Bohuslav ^a,b   Dvořák, Josef ^a   Krčmová, Lenka ^a   Hyšpler, Radomír ^a   Urbánek, Lubor ^a   Solichová, Dagmar ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Chemotherapy induced diarrhea; Intestinal permeability; Retinol; Retinyl esters

Indexed keywords

ANTIINFECTIVE AGENT; CISPLATIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; LACTULOSE; MANNITOL; MITOMYCIN C; RETINOL; RETINOL ESTER; XYLOSE;

ADULT; AGED; ARTICLE; CAPILLARY GAS CHROMATOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; FEMALE; HUMAN; MALE; RANK SUM TEST; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CASE-CONTROL STUDIES; DIARRHEA; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; INTESTINAL ABSORPTION; LACTULOSE; MALE; MANNITOL; MIDDLE AGED; PERMEABILITY; PROGNOSIS; RECTAL NEOPLASMS; VITAMIN A; XYLOSE; YOUNG ADULT;

EID: 58149233845     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e318174dbb9     Document Type: Article

References (18)

1. Kornblau S, Benson AB, Catalano R, et al. Management of cancer treatment-related diarrhea: issues and therapeutic strategies. J Pain Symptom Manage. 2000;19:118-129.
2. DeMeo MT, Mutlu EA, Keshavarzian A, et al. Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol. 2002;34:385-396.
3. Bjarnason I, Macpherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology. 1995;1995:1566-1581.
4. Uil JJ, van Elburg RM, van Overbeek FM, et al. Clinical implications of the sugar absorption test: intestinal permeability test to assess mucosal barrier function. Scand J Gastroenterol. 1997;32:70-78.
5. Melichar B, Dvorak J, Hyspler R, et al. Intestinal permeability in the assessment of intestinal toxicity of cytotoxic agents. Chemotherapy. 2005;51:336-338.
6. Harrison EH, Hussain MM. Mechanisms involved in the intestinal digestion and absorption of dietary vitamin A. J Nutr. 2001;131:1405-1408.
7. Johnson EJ, Krasinski SD, Howard LJ, et al. Evaluation of vitamin A absorption by using oil-soluble and water-miscible vitamin A preparations in normal adults and in patients with gastrointestinal disease. Am J Clin Nutr. 1992;55:857-864.
8. Melichar B, Kohout P, Bratova M, et al. Intestinal permeability in patients with chemotherapy-induced stomatitis. J Cancer Res Clin Oncol. 2001;127:314-318.
9. Urbanek L, Krcmova L, Solichova D, et al. Development and validation of a liquid chromatography method for the simultaneous determination of alpha-tocopherol, retinol and retinyl esters in human serum using a monolithic column for the monitoring of anticancer therapy side effects. J Sep Sci. 2006;29:2485-2493.
10. Carneiro-Filho BA, Lima IPF, Araujo DH, et al. Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis. Dig Dis Sci. 2004;49:65-72.
11. Yanez JA, Teng XW, Roupe KA, et al. Chemotherapy induced gastrointestinal toxicity in rats: involvement of mitochondrial DNA, gastrointestinal permeability and cyclooxygenase-2. JPharm Pharm Sci. 2003;6:308-314.
12. Parrilli G, Iaffaioli RV, Capuano G, et al. Changes in intestinal permeability to lactulose by cytotoxic chemotherapy. Cancer Treat Rep. 1982;66:1435-1436.
13. Parrilli G, Iaffaioli RV, Martorano M, et al. Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer. Cancer Res. 1989;49:3689-3691.
14. Kohout P, Cerman J, Bratova M, et al. Small bowel permeability in patients with cytostatic therapy. Nutrition. 1999;15:546-549.
15. Daniele B, Secondulfo M, De Vivo R, et al. Effect of chemotherapy with 5-fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer. J Clin Gastroenterol. 2001;32:228-230.
16. Fazeny-Dorner B, Vetl M, Wenzel C, et al. Alterations in intestinal permeability following the intensified polydrug-chemotherapy IFADIC (ifosfamide, Adriamycin, dacarbazine). Cancer Chemother Pharmacol. 2002;49:294-298.
17. Sundstrom GM, Wahlin A, Nordin-Anderson I, et al. Intestinal permeability in patients with acute myeloid leukemia. Eur J Haematol. 1998;61:250-254.
18. van der Hulst RRWJ, von Meyenfeldt MF, van Kreel BK, et al. Gut permeability, intestinal morphology, and nutritional depletion. Nutrition. 1998;14:1-6.